Deep Track Capital’s Terns Pharmaceuticals TERN Stock Holding History

Deep Track Capital’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,073,877	Closed	-$56.6M	–	80
2026 Q1	$56.6M	Buy	1,073,877 +304,829	+40%	+$12.5M	0.92%	32
2025 Q4	$31.1M	Sell	769,048 -6,725,952	-90%	-$155M	0.55%	37
2025 Q3	$56.3M	Hold	7,495,000	–	–	1.57%	20
2025 Q2	$28M	Buy	7,495,000 +1,918,442	+34%	+$5.99M	0.9%	29
2025 Q1	$15.4M	Hold	5,576,558	–	–	0.5%	42
2024 Q4	$30.9M	Hold	5,576,558	–	–	1.15%	29
2024 Q3	$46.5M	Sell	5,576,558 -523,442	-9%	-$4.31M	1.48%	24
2024 Q2	$41.5M	Hold	6,100,000	–	–	1.24%	31
2024 Q1	$40M	Hold	6,100,000	–	–	1.15%	35
2023 Q4	$39.6M	Buy	6,100,000 +100,000	+2%	+$529K	1.32%	34
2023 Q3	$30.2M	Buy	6,000,000 +4,900,808	+446%	+$31.1M	1.16%	29
2023 Q2	$9.62M	Buy	+1,099,192	New	+$12.8M	0.45%	42

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Deep Track Capital's TERN Position: Q2 2026 in Review

Deep Track Capital sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 1,073,877 shares — an estimated $56.6M sold.

Deep Track Capital first reported a position in TERN in Q2 2023 and held it in 12 quarters. The position peaked at $56.6M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Deep Track Capital reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Deep Track Capital sold 1,073,877 Terns Pharmaceuticals shares in Q2 2026, an estimated $56.6M.
Deep Track Capital first reported a position in Terns Pharmaceuticals in Q2 2023 and held it in 12 quarters.
Deep Track Capital's Terns Pharmaceuticals position peaked at $56.6M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.